Health Bulletin 30/December/2021 Roshni Dhar30 Dec 2021 5:59 PM ISTHere are Top health stories of the dayNiti Aayog Releases Health Index NEET PG Impasse Continues, More Doctors Join Strike MBBS, BDS Admissions...
Cipla bags DCGI nod for COVID-19 oral antiviral, all set to launch Cipmolnu in India Ruchika Sharma28 Dec 2021 3:00 PM ISTMolnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2.
Cipla bags USFDA nod for Lanreotide Injection Ruchika Sharma20 Dec 2021 12:54 PM ISTMumbai: Cipla Limited along with its subsidiary Cipla USA, Inc., announced that it has received final approval for its Lanreotide Injection, from the...
Cipla to acquire 33 percent stake in Clean Max Auriga Power Ruchika Sharma16 Dec 2021 3:27 PM ISTMumbai: Cipla Limited has announced that the company has acquired up to 33% of partnership interest in Clean Max Auriga Power LLP (Limited Liability...
Cipla to give nebulisers to primary health care centres in India Ruchika Sharma13 Dec 2021 1:31 PM ISTNew Delhi: Homegrown pharma major Cipla Ltd on Friday said it will donate 5,000 nebulisers to primary health care centres in India as part of its...
Cipla launches Spirofy for early diagnosis for COPD Ruchika Sharma17 Nov 2021 1:03 PM ISTMumbai: Pharma major, Cipla Limited, announced the launch of Spirofy, India's first pneumotach based portable, wireless Spirometer, on World COPD...
Cipla to be listed in Dow Jones Sustainability Index for emerging markets Ruchika Sharma16 Nov 2021 12:00 PM ISTMumbai: Cipla Limited has recently announced that the company has been selected in the S&P Dow Jones Sustainability Index (DJSI) for the Emerging...
Cipla resolves funding dispute with Pulmatrix over asthma drug Pumazole Ruchika Sharma12 Nov 2021 1:31 PM ISTPulmazole is an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
Cipla unit gets termination notice on Rs 1560 crore acquisition deal with Avenue Therapeutics Hina Zahid5 Nov 2021 6:11 PM ISTIn November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US based speciality business...
Eli Lilly, Cipla ink pact for Humalog,Trulicity to treat diabetes Ruchika Sharma4 Oct 2021 2:05 PM ISTNew Delhi: Eli Lilly and Company (India) Pvt. Ltd., is a wholly owned subsidiary of Eli Lilly and Company, a global biopharmaceutical...
Cipla eyes acquisitions after Covid windfall: Bloomberg Ruchika Sharma2 Oct 2021 9:30 AM ISTNew Delhi: Cipla Ltd., one of India's largest drugmakers, has built up a war chest and is on the prowl for deals that can boost growth beyond the...
Cipla, Kemwell Biopharma collaborate to develop, commercialize biosimilars Ruchika Sharma26 Aug 2021 10:00 AM ISTMumbai: Cipla Limited, a global pharmaceutical company and Kemwell Biopharma Private Limited, a biopharmaceutical Contract Development and...
